Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Change in Receivables (2022 - 2025)

Lucid Diagnostics (LUCD) has disclosed Change in Receivables for 4 consecutive years, with $177000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Receivables rose 245.08% year-over-year to $177000.0, compared with a TTM value of $383000.0 through Sep 2025, up 2152.94%, and an annual FY2023 reading of $28000.0, up 115.3% over the prior year.
  • Change in Receivables was $177000.0 for Q3 2025 at Lucid Diagnostics, down from $312000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $312000.0 in Q2 2025 and bottomed at -$122000.0 in Q3 2024.
  • Average Change in Receivables over 4 years is $24500.0, with a median of $9000.0 recorded in 2023.
  • Peak annual rise in Change in Receivables hit 1287.5% in 2024, while the deepest fall reached 771.43% in 2024.
  • Year by year, Change in Receivables stood at -$14000.0 in 2022, then skyrocketed by 271.43% to $24000.0 in 2023, then tumbled by 608.33% to -$122000.0 in 2024, then soared by 245.08% to $177000.0 in 2025.
  • Business Quant data shows Change in Receivables for LUCD at $177000.0 in Q3 2025, $312000.0 in Q2 2025, and $16000.0 in Q1 2025.